CVS Pharmacy suspends sale of Zantac heartburn medication for fear it may cause cancer

CVS Pharmacy announced on Saturday that it has suspended all Zantac brand names and CVS Health brand ranitidine products until further notice

The announcement comes in response to an FDA notice that ranitidine products may contain a carcinogen and cause cancer.

While Zantac and ranitidine products have not been recalled and the FDA does not recommend patients to stop taking these products, customers can still return the products to CVS for a refund.

Ranitidine is an H2 blocker that is taken to provide relief from heartburn.

CVS states that they will continue to sell other unused H2 blockers, including Pepcid, Tagamet and other equivalents.

Source link

Back to top button